AXS 07 eliminated migraine pain, and substantially and significantly prevented progression of migraine pain in the INTERCEPT phase III trial in the early treatment of migraine.- Axsome Therapeutics
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest